CranioSense awarded $5.5M in NIH and DoD federal grants for non-invasive ICP monitoring — "Holy Grail" of battlefield casualty care
Summary
CranioSense announced receipt of approximately $5.5 million in non-dilutive federal funding on December 17, 2025 through two sources: the NIH Blueprint MedTech Program and the US Department of Defense's Joint Warfighter Medical Research Program (JWMRP). The NIH funding supports device development while the DoD funding addresses the military's need for non-invasive ICP monitoring in austere combat environments. LTC (Ret.) Doug Powell MD, former Prolonged Field Care consultant to US Army Special Operations Command, said: "Noninvasive ICP monitoring has long been considered a 'Holy Grail' of PFC, and CranioSense's work represents a meaningful step toward closing that gap." CranioSense uses near-infrared optical sensors to monitor brain pressure non-invasively. Founded 2023 by CEO Ryan Myers PhD MBA.
Why it matters
Dual NIH and DoD funding for CranioSense validates their technology from two independent expert committees — scientific (NIH Blueprint MedTech, which funds only highly meritorious device concepts) and military medical (JWMRP, which funds only operationally critical needs). Non-invasive ICP monitoring is needed simultaneously on battlefields and in every community hospital ED — the DoD validation creates both a captive first-mover market and civilian healthcare credibility.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial